KEGG   PATHWAY: bacu05213
Entry
bacu05213                   Pathway                                
Name
Endometrial cancer - Balaenoptera acutorostrata scammoni (minke whale)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
bacu05213  Endometrial cancer
bacu05213

Organism
Balaenoptera acutorostrata scammoni (minke whale) [GN:bacu]
Gene
103004366  EGF; epidermal growth factor [KO:K04357]
103017029  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
103012691  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
103012931  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
103014043  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
103008077  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
103009307  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
103007464  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
102998704  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
103010966  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
103018082  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]
103002026  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
103013147  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
103004139  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
103010071  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
103005702  BAD; BCL2 associated agonist of cell death [KO:K02158]
102999779  FOXO3; forkhead box O3 [KO:K09408]
103010512  GRB2; growth factor receptor bound protein 2 [KO:K04364]
102999196  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
103019365  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
103006545  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
103015457  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
103004931  NRAS; neuroblastoma RAS viral oncogene homolog [KO:K07828]
103020975  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
103002372  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
103014337  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
103017381  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103018627  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
102999619  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103002590  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
102998249  ELK1; ELK1, ETS transcription factor [KO:K04375]
103015439  MLH1; mutL homolog 1 [KO:K08734]
102999370  CDH1; cadherin 1 [KO:K05689]
103019097  CTNNB1; catenin beta 1 [KO:K02105]
103008224  CTNNA2; catenin alpha 2 [KO:K05691]
103017413  CTNNA1; catenin alpha 1 [KO:K05691]
103012066  CTNNA3; catenin (cadherin-associated protein), alpha 3 [KO:K05691]
103006014  AXIN1; axin 1 [KO:K02157]
103006133  AXIN2; axin 2 [KO:K04385]
103001169  APC; APC, WNT signaling pathway regulator [KO:K02085]
103014178  APC2; APC2, WNT signaling pathway regulator [KO:K02085]
102998893  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
103018264  TCF7; transcription factor 7 (T-cell specific, HMG-box) [KO:K02620]
103010166  TCF7L1; transcription factor 7 like 1 [KO:K04490]
103010923  TCF7L2; transcription factor 7 like 2 [KO:K04491]
103020844  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]
103016933  MYC; v-myc avian myelocytomatosis viral oncogene homolog [KO:K04377]
103013404  CCND1; cyclin D1 [KO:K04503]
103003426  TP53; tumor protein p53 [KO:K04451]
103005082  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
103012188  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]
103016967  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]
103020367  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]
103019528  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]
102999845  putative Bcl-2 homologous antagonist/killer 2-like [KO:K14021]
103017537  DDB2; damage specific DNA binding protein 2 [KO:K10140]
103009875  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
103002640  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
bacu04010  MAPK signaling pathway
bacu04012  ErbB signaling pathway
bacu04060  Cytokine-cytokine receptor interaction
bacu04110  Cell cycle
bacu04115  p53 signaling pathway
bacu04151  PI3K-Akt signaling pathway
bacu04310  Wnt signaling pathway
bacu04520  Adherens junction
KO pathway
ko05213   
LinkDB

DBGET integrated database retrieval system